Overview

AZD6738 & Gemcitabine as Combination Therapy

Status:
Recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
A dose escalation trial to assess the safety of AZD6738 in combination with gemcitabine in participants with advanced solid tumours.
Phase:
Phase 1
Details
Lead Sponsor:
CCTU- Cancer Theme
Collaborator:
AstraZeneca
Treatments:
Gemcitabine